梅马根:一项IIa/IIb期的开放标签试验,用于测试梅曼丁在状细胞患者的安全性和耐受性
Ariel Koren1, Carina Levin1,2, Leonid Livshits3,4,5,6
1Pediatric Hematology Unit Emek Medical Center Afula Israel.
HemaSphere
|January 14, 2026
概括
孟坦丁是状细胞病 (SCD) 患者的安全和耐受药物,有可能减少儿童住院治疗,改善红细胞健康. 这种辅助疗法可以补充现有的氧化碳胺治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 状细胞疾病研究研究
背景情况:
- 状细胞疾病 (SCD) 涉及红细胞 (RBC) 脱水和过载.
- 孟曼丁是一种N-甲基-D-酸盐受体对抗剂,显示出缓解这些红细胞异常的潜力.
研究的目的:
- 评估在SCD患者中孟坦丁的安全性和耐受性.
- 评估孟坦因作为氧化碳胺胺的补充疗法的疗效.
主要方法:
- 一年期,剂量升级的IIa/IIb期试验 (MeMAGEN) 涉及17名SCD患者,他们接受碳胺.
- 剂量范围:儿童/青少年每天5-15毫克,成人每天5-20毫克.
- 在整个研究过程中进行了临床和实验室评估.
主要成果:
- 孟坦丁在儿童和成人SCD患者中耐受性良好.
- 在儿科参与者中观察到医院住院日数减少.
- 在K+泄漏升高的小组中,孟坦因减少了K+损失,增加了血红蛋白水平.
- 实验室安全测试保持稳定或显示最小的变化.
结论:
- 孟坦丁在儿童和成人SCD患者中安全且耐受良好,包括那些服用氧化碳胺的人.
- 孟曼丁显示出作为SCD的支持性,低成本治疗选择的潜力.
- 进一步的研究可能会探索记忆素在改善红细胞功能和SCD的临床结果中的作用.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...


